Share this article

print logo

Athenex launches drug trial for Oraxol

Buffalo drug development company Athenex Inc. is launching an early-stage clinical trial for an oral form of a drug that potentially could be used as part of a treatment for gastric cancer.

The Phase 1b clinical trial of its Oraxol drug, administered in conjunction with another drug, ramucirumab, is underway, with a patient recently receiving the first dose of the drug, the company said.

Oraxol is an oral formulation of paclitaxel, a drug that is used to treat forms of advanced cancer. Athenex also is working on a more advanced Phase 3 clinical trial using Oraxol as a treatment for breast cancer.

There are no comments - be the first to comment